High‐throughput fabrication of vascularized adipose microtissues for 3D bioprinting
Lara Benmeridja,Lise De Moor,Elisabeth De Maere,Florian Vanlauwe,Michelle Ryx,Liesbeth Tytgat,Chris Vercruysse,Peter Dubruel,Sandra Van Vlierberghe,Phillip Blondeel,Heidi Declercq
DOI: https://doi.org/10.1002/term.3051
2020-05-11
Journal of Tissue Engineering and Regenerative Medicine
Abstract:<p>For patients with soft tissue defects, repair with autologous in vitro‐engineered adipose tissue could be a promising alternative to current surgical therapies. A volume‐persistent engineered adipose tissue construct under in vivo conditions can only be achieved by early vascularization after transplantation. The combination of 3D bioprinting technology with self‐assembling microvascularized units as building blocks, can potentially answer the need for a microvascular network. In the present study, co‐culture spheroids combining adipose derived stem cells (ASC) and human umbilical vein endothelial cells (HUVEC) were created with an ideal geometry for bioprinting. When applying the favorable seeding technique and condition, compact viable spheroids were obtained, demonstrating high adipogenic differentiation and capillary‐like network formation after 7 and 14 days of culture, as shown by live/dead analysis, immunohistochemistry and RT‐qPCR. Moreover, we were able to successfully 3D bioprint the encapsulated spheroids, resulting in compact viable spheroids presenting capillary‐like structures, lipid droplets and spheroid outgrowth after 14 days of culture. This is the first study that generates viable high‐throughput (pre‐)vascularized adipose microtissues as building blocks for bioprinting applications using a novel ASC/HUVEC‐co‐culture‐spheroid model, which enables both adipogenic differentiation while simultaneously supporting the formation of pre‐vascular‐like structures within engineered tissues in vitro.</p>
biotechnology & applied microbiology,engineering, biomedical,cell & tissue engineering,cell biology